Breastfeeding is associated with enhanced intestinal gluconeogenesis in infants

Duan Ni1,2,3, Jian Tan1,4, Laurence Macia1,4,5

  • 1Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.

BMC Medicine
|March 8, 2024
PubMed

Insights

Breastfeeding enhances intestinal gluconeogenesis in infants, a key mechanism for metabolic health. This finding in human infants is consistent with observations in other mammals, highlighting its biological importance.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Developmental Biology

Background:

  • Breastfeeding (BF) offers significant metabolic advantages to infants, potentially reducing risks of metabolic syndrome, obesity, and diabetes later in life.
  • The precise biological mechanisms underlying these benefits remain incompletely understood.
  • Investigating the impact of breastfeeding on infant metabolic organs is crucial for elucidating these mechanisms.

Purpose of the Study:

  • To investigate the effects of breastfeeding on the metabolic organs of infants.
  • To explore the molecular pathways through which breastfeeding influences infant metabolism.
  • To identify potential mechanisms linking breastfeeding to long-term metabolic health.

Main Methods:

  • A comprehensive review of existing literature on breastfeeding's influence on offspring metabolic organs in both animal models and human studies.
  • Analysis of a microarray dataset examining intestinal gene expression in infants fed breast milk versus formula milk.

Main Results:

  • Reanalysis of microarray data revealed that breastfeeding is associated with enhanced intestinal gluconeogenesis in infants.
  • This finding in human infants mirrors observations in other mammalian species, where breastfeeding has also been linked to increased gluconeogenesis.

Conclusions:

  • Breastfeeding promotes enhanced intestinal gluconeogenesis in infants, likely contributing to its metabolic benefits.
  • This mechanism may play a role in fine-tuning metabolic homeostasis, supporting infant health.
  • The conservation of this effect across species suggests significant biological importance.
Abstract

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
928
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K